WeVote

Bill

Bill

SB 2045

HIV medications; prohibit health plans and Medicaid from restricting dispensing of HIV/AIDS treatment.

2025 Regular Session

Bill prohibits health insurers and Medicaid from restricting HIV medication dispensing through prior authorization or quantity limits to improve treatment access.

Died In Committee
0
WeVote Research Nonpartisan
Bill Summary · SB 2045

Legislative bill overview

SB 2045 would prohibit health insurance plans and Mississippi's Medicaid program from imposing restrictions on the dispensing and coverage of HIV/AIDS medications. The bill aims to ensure that patients with HIV can access antiretroviral and related treatments without prior authorization requirements, quantity limits, or other utilization management tools that insurers typically use to control costs.

Why is this important

HIV treatment has evolved dramatically—modern antiretroviral therapy can reduce viral loads to undetectable levels, allowing people with HIV to live normal lifespans and preventing transmission (undetectable equals untransmittable). However, insurance restrictions like prior authorization can delay treatment initiation, interrupt therapy continuity, or force patients onto less effective drugs. This bill directly affects medication access equity in Mississippi, where HIV prevalence among certain populations exceeds national averages.

Potential points of contention

  • Cost concerns: Insurers argue utilization management controls drug spending; removing restrictions could increase premiums or reduce coverage for other services
  • Prior authorization trade-offs: While delays harm patients, some argue blanket prohibitions eliminate insurers' ability to prevent wasteful prescribing or drug interactions
  • Implementation scope: Defining "restrictions" broadly could encompass quantity limits for legitimate reasons (e.g., distinguishing between 30-day and 90-day supplies) versus blanket denials

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.